secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2025-09-22T23:59:59+00:00
Accession:  0001193125-25-211305
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAtla granted Nasdaq continued listing with conditions through Feb 2026
-------------------------------------------------------------------------

- Nasdaq Panel approved continued listing pending transfer to Capital Market by Sept 26, 2025 (filed Sept 18).
- Must demonstrate compliance with Minimum Stockholders' Equity Requirement by Dec 31, 2025.
- Must demonstrate compliance with Minimum Bid Price Requirement by Feb 2, 2026.
- Company believes it can meet both deadlines but provides no assurance.
- Previously disclosed delisting risk from failure to meet bid price and equity requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000119312525211305/0001193125-25-211305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000119312525211305/bcab-20250916.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-211305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer